Afya Limited confirmed that discussions with Yduqs Participações S.A. regarding a potential business combination are at an early stage, following a disclosure by Yduqs on August 24, 2026. No binding agreement or commitment has been entered into, and there is no assurance the talks will result in a transaction. Afya operates as a leading medical education group in Brazil.

Afya Limited filed its unaudited interim condensed consolidated financial statements for the six-month period ended June 30, 2026. The company reported revenue of R$1,984,809 thousand and net income attributable to owners of R$454,137 thousand, compared to R$1,855,760 thousand in revenue and R$424,331 thousand in net income for the same period in 2025. Basic earnings per share increased to 5.10 from 4.69. The company declared dividends totaling R$307,377 thousand during the period. Afya Limited operates in the higher education and medical practice solutions industry.

Afya Limited reported second-quarter and first-half 2026 financial results for the period ending June 30, 2026. Second-quarter revenue increased 5.7% year-over-year to R$972.1 million, while adjusted EBITDA rose 1.4% to R$406.5 million with a margin of 41.8%. Net income grew 14.0% to R$201.3 million, yielding basic earnings per share of R$2.22. For the first half, revenue reached R$1,984.8 million and net income totaled R$463.1 million. The company returned R$447.9 million to shareholders through dividends and share repurchases, representing 105.8% of free cash flow to equity. Additionally, Marcelo Ken Suhara was appointed Chair Member of the Audit, Risks and Ethics Committee following the passing of João Paulo Seibel de Faria. Afya operates in the medical education sector as a leading group providing educational services and medical practice solutions in Brazil.